Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …

News

Boehringer Ingelheim and Enara Bio to collaborate on cancer immunotherapies

January 12, 2021
Manufacturing and Production Boehringer Ingelheim, Cancer, Enara Bio

Boehringer Ingelheim and Enara Bio have entered into a strategic collaboration and licensing agreement to research and develop novel targeted …

News

Promising new treatment for drug-resistant prostate cancer

January 12, 2021
Manufacturing and Production Cancer

A new experimental drug could offer a promising treatment strategy for men with advanced, drug-resistant prostate cancer, researchers have said. …

News
richard_francis

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …

Appointment
lilly_building_with_american_flag_web

Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial

January 11, 2021
Sales and Marketing Alzheimer's, Eli Lilly

Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …

News
roche_dark_0

Roche’s influenza drug Xofluza gets EU approval

January 11, 2021
Sales and Marketing EC, Roche, influenza

The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …

News

MaxCyte signs licensing deal with Myeloid Therapeutics

January 11, 2021
Sales and Marketing MaxCyte, Myeloid Therapeutics

MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …

News

Sanofi to acquire Kymab for $1.1bn

January 11, 2021
Sales and Marketing Malin, Sanofi, kymab

Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …

News
vaccination

Seven mass vaccination sites open in England

January 11, 2021
Sales and Marketing COVID-19, UK, Vaccine

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 8, 2021
Medical Communications

Almost all of Pharmafile.com’s most popular stories this week focused on developments in the global mission to vaccinate against COVID-19. …

News

Pfizer’s COVID-19 vaccine protects against variants, research shows

January 8, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …

News

Bayer and CureVac to collaborate on COVID-19 vaccine candidate

January 8, 2021
Medical Communications Bayer, COVID-19, Vaccine

Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …

News
bham_uni

Birmingham research paves way for new anti-fibrotic glaucoma treatment

January 8, 2021
Medical Communications Glaucoma, University of Birmingham

New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …

News

Arthritis drugs could save lives of COVID-19 patients, study finds

January 8, 2021
Medical Communications COVID-19

Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …

News

NICE recommends AstraZeneca’s FORXIGA for heart failure

January 7, 2021
AstraZeneca, NICE

NICE has issued a positive Final Appraisal Document (FAD) recommending AstraZeneca’s FORXIGA (dapagliflozin) as an option for treatment of symptomatic …

News
mcr_glasgow

New COVID-19 screening hub to be established in Scotland

January 7, 2021
COVID-19

A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …

News
sputnik-v-covid-19-vaccine-scaled-e1599484511213

Bolivia registers Russia’s Sputnik V COVID-19 vaccine

January 7, 2021
COVID-19, Vaccine

Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …

News
fujifilm

Fujifilm to invest $2bn in new US cell culture production site

January 7, 2021
Fujifilm Diosynth Biotechnologies

Fujifilm has announced it is investing $2 billion to establish a new large-scale cell culture production site in the US. …

News
moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 6, 2021
Research and Development COVID-19, Vaccine

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026